{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T21:15:04Z","timestamp":1791407704726,"version":"4.3.3"},"reference-count":42,"publisher":"Wiley","issue":"S360","license":[{"start":{"date-parts":[[2007,8,23]],"date-time":"2007-08-23T00:00:00Z","timestamp":1187827200000},"content-version":"vor","delay-in-days":6200,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Acta Psychiatr Scand"],"published-print":{"date-parts":[[1990,9]]},"abstract":"<jats:p>In addition to being effective in depressive disorders, monoamine oxidase inhibitors (MAOIs) have been shown to be effective in controlled studies of patient with panic disorder with agoraphobia, social phobia, atypical depression or mixed anxiety and depression, bulimia, posttraumatic stress disorder (PTSD) and borderline personality disorder. Uncontrolled case reports have noted MAOI efficacy in obsessive\u2010compulsive disorder (OCD), trichotillomania, dysmorphophobia and avoidant personality disorder. Reversible inhibitors of MAO\u2010A (RIMAs) appear safer than the classical irreversible MAOIs since they have less potential to increase blood pressure. They have not been studied as yet, however, in most of the conditions responsive to MAOIs. If RIMAs are found effective in these disorders, they would probably achieve wider use than MAOIs because they are safer and tend to cause fewer side effects.<\/jats:p>","DOI":"10.1111\/j.1600-0447.1990.tb05321.x","type":"journal-article","created":{"date-parts":[[2007,8,23]],"date-time":"2007-08-23T12:10:58Z","timestamp":1187871058000},"page":"29-34","source":"Crossref","is-referenced-by-count":39,"title":["Reversible and irreversible monoamine oxidase inhibitors in other psychiatric disorders"],"prefix":"10.1111","volume":"82","author":[{"given":"M. R.","family":"Liebowitz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Hollander","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Schneier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Campeas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Welkowitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Hatterer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Fallon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2007,8,23]]},"reference":[{"key":"e_1_2_1_2_2","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1984.01790180039005"},{"key":"e_1_2_1_3_2","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1988.01800260037004"},{"key":"e_1_2_1_4_2","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1980.01780140053006"},{"key":"e_1_2_1_5_2","first-page":"252","article-title":"Pharmacotherapy of social phobia: an interim report of a placebo\u2010controlled comparison of phenelzine and atenolol","volume":"49","author":"Liebowitz MR.","year":"1988","journal-title":"J Clin Psychiatry"},{"key":"e_1_2_1_6_2","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1988.01800290091011"},{"key":"e_1_2_1_7_2","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.143.11.1495a"},{"key":"e_1_2_1_8_2","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1988.01800260015002"},{"key":"e_1_2_1_9_2","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.145.10.1289"},{"key":"e_1_2_1_10_2","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.138.9.1250"},{"key":"e_1_2_1_11_2","first-page":"1249","article-title":"MAOI for obsessive compulsive disorder","volume":"138","author":"Jenike M.","journal-title":"Am J Psychiatry"},{"key":"e_1_2_1_12_2","first-page":"267","article-title":"MAO inhibitor in trichotillomania associated with depression case report","volume":"45","author":"Krishnan RR.","year":"1984","journal-title":"J Clin Psychiatry"},{"key":"e_1_2_1_13_2","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.141.11.1463"},{"key":"e_1_2_1_14_2","doi-asserted-by":"publisher","DOI":"10.1016\/0010-440X(86)90051-9"},{"key":"e_1_2_1_15_2","first-page":"562","article-title":"Panic attacks in outpatients with depression: response to antidepressant treatment","volume":"21","author":"Robinson DS.","year":"1985","journal-title":"Psycho-pharmacol Bull"},{"key":"e_1_2_1_16_2","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.134.6.572"},{"key":"e_1_2_1_17_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0447.1984.tb01206.x"},{"key":"e_1_2_1_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/0165-0327(89)90072-4"},{"key":"e_1_2_1_19_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.1.5136.1491"},{"key":"e_1_2_1_20_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.1.5221.225"},{"key":"e_1_2_1_21_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.1.5270.6"},{"key":"e_1_2_1_22_2","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.116.533.387"},{"key":"e_1_2_1_23_2","first-page":"55","article-title":"Therapeutic response to phenelzine in patients with panic disorder and agoraphobia with panic attacks","volume":"48","author":"Buigues J.","year":"1987","journal-title":"J Clin Psychiatry"},{"key":"e_1_2_1_24_2","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1985.01790300097013"},{"key":"e_1_2_1_25_2","doi-asserted-by":"publisher","DOI":"10.1097\/00004714-198604000-00006"},{"key":"e_1_2_1_26_2","doi-asserted-by":"publisher","DOI":"10.1097\/00004714-198808000-00008"},{"key":"e_1_2_1_27_2","unstructured":"VersianiM. NardiAE. MundimFD. AlvesAB. NickE. LiebowitzMR.Phannacotherapy of social phobia: a controlled study with moclobemide and phenelzine. In preparation."},{"key":"e_1_2_1_28_2","first-page":"217","article-title":"An open trial of MAO inhibitors in bulimia","volume":"45","author":"Stewart JW.","year":"1984","journal-title":"J Clin Psychiatry"},{"key":"e_1_2_1_29_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0193-953X(18)30996-1"},{"key":"e_1_2_1_30_2","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S0193-953X(18)30937-7","article-title":"Interrelationship of hysteroid dysphoria and borderline personality disorder","volume":"4","author":"Liebowitz MR.","year":"1981","journal-title":"Psychiatr Clin North Am"},{"key":"e_1_2_1_31_2","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.127.9.1141"},{"key":"e_1_2_1_32_2","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1981.01780290074008"},{"key":"e_1_2_1_33_2","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.150.2.252"},{"key":"e_1_2_1_34_2","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1987.01800230056010"},{"key":"e_1_2_1_35_2","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1989.01810040041007"},{"key":"e_1_2_1_36_2","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.146.6.768"},{"key":"e_1_2_1_37_2","doi-asserted-by":"publisher","DOI":"10.1097\/00004714-198910000-00008"},{"key":"e_1_2_1_38_2","first-page":"70","article-title":"Differential response patterns to MAO inhibitors and tricyclics","volume":"45","author":"Nies A.","year":"1984","journal-title":"J Clin Psychiatry"},{"key":"e_1_2_1_39_2","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.145.3.306"},{"key":"e_1_2_1_40_2","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1989.01810090029005"},{"key":"e_1_2_1_41_2","doi-asserted-by":"publisher","DOI":"10.1016\/0165-1781(86)90063-6"},{"key":"e_1_2_1_42_2","first-page":"167","article-title":"A unified biosocial theory of personality and its role in the development of anxiety states","volume":"3","author":"Cloninger CR.","year":"1986","journal-title":"Psychiatry Dev"},{"key":"e_1_2_1_43_2","doi-asserted-by":"publisher","DOI":"10.1016\/0165-1781(87)90054-0"}],"container-title":["Acta Psychiatrica Scandinavica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1600-0447.1990.tb05321.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1600-0447.1990.tb05321.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,22]],"date-time":"2023-10-22T09:26:42Z","timestamp":1697966802000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1600-0447.1990.tb05321.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1990,9]]},"references-count":42,"journal-issue":{"issue":"S360","published-print":{"date-parts":[[1990,9]]}},"alternative-id":["10.1111\/j.1600-0447.1990.tb05321.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1600-0447.1990.tb05321.x","archive":["Portico"],"relation":{},"ISSN":["0001-690X","1600-0447"],"issn-type":[{"value":"0001-690X","type":"print"},{"value":"1600-0447","type":"electronic"}],"subject":[],"published":{"date-parts":[[1990,9]]}}}